Who founded Rigimmune?

Rigimmune was founded by Anna Marie Pyle, Akiko Iwasaki.

Who are Rigimmune's investors?

Rigimmune's investors include F-Prime Capital.

Where is Rigimmune headquartered?

Rigimmune is headquartered in Farmington, US.

Rigimmune

Farmington, US · 1 known investors

Find your way into Rigimmune

519 people in our graph share verified history with the Rigimmune team — schools, employers, funds. One of them is your warm intro.

Karthik Ardhanareeswaranunlockedknows Akiko Iwasaki · together at Yale University School of Medicine (overlapped)

knows the team · via University of Colorado Boulder

×3knows the team · via Princeton University

knows the team · via Columbia University in the City of New York

×3knows the team · via Yale University

knows the team · via University of Toronto

RIGImmune is a biotechnology company developing stem loop RNA (SLR) therapeutics that activate the RIG-I innate immune sensor and the Type I interferon pathway for use against serious respiratory diseases. It operates a non-lipid-nanoparticle delivery platform called NEED (Nano-Emulsion Enhanced Delivery) for delivering RNA therapeutics directly to the respiratory tract.

Biotech Healthtech Medical Devices

Founders & leadership

Anna Marie Pyle inCo-founderCo-founder of RIGImmune, a biotechnology company developing RNA therapeutics for respiratory diseases. Pyle's research background spans RNA structural biology, viral and immune-related RNA mechanisms, and protein-RNA interactions using biophysical and crystallographic methods.

Akiko Iwasaki inCo-founderAkiko Iwasaki studies viral infectious diseases and antiviral immunity, with expertise in the interplay between endogenous retroviruses and immune system mechanisms. She is co-founder of RIGImmune, a biotechnology company developing stem loop RNA therapeutics for respiratory diseases.

Investors · 1

F-Prime CapitalCambridge · $3M – $10M

Founder mafia

3 people who came through Rigimmune went on to found or lead other companies.

Anna Marie PyleCo-founderFounded RNA Connect Akiko IwasakiCo-founderFounded Xanadu Bio Kazuhiro ItoScientific Advisory BoardFounded Pulmocide

Competitors · 3

by search overlap

VerImmune10 shared keywordsVerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity. The company targets cancer patients across a broad range of cancer types.

Inimmune7 shared keywordsInimmune is a clinical-stage biotech company developing immunotherapies for allergy, cancer, infectious, and autoimmune diseases. The company combines immunology and vaccine expertise to advance its clinical and pre-clinical pipeline.

BellBrook Labs7 shared keywordsBellBrook Labs supplies life-science research products and services to laboratories, distributed internationally through regional partners across Europe, Asia, and Oceania. Its offerings serve the biotechnology and drug-discovery research market.

Companies competing with Rigimmune for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Rigimmune do?: RIGImmune is a biotechnology company developing stem loop RNA (SLR) therapeutics that activate the RIG-I innate immune sensor and the Type I interferon pathway for use against serious respiratory diseases. It operates a non-lipid-nanoparticle delivery platform called NEED (Nano-Emulsion Enhanced Delivery) for delivering RNA therapeutics directly to the respiratory tract.
Who founded Rigimmune?: Rigimmune was founded by Anna Marie Pyle, Akiko Iwasaki.
Who are Rigimmune's investors?: Rigimmune's investors include F-Prime Capital.
Where is Rigimmune headquartered?: Rigimmune is headquartered in Farmington, US.